Yazan F. Madanat, M.D. is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. Dr. Madanat is the Interim Clinical Chief in the Division of Hematology and Medical Oncology. He is a Eugene P. Frenkel, M.D. Scholar in Clinical Medicine and the Director of the Leukemia Program at The Harold C. Simmons Comprehensive Cancer Center. Dr. Madanat earned his medical degree at the University of Jordan. He completed his residency training in internal medicine at the Cleveland Clinic and then received advanced training in hematology and medical oncology through a fellowship at the Cleveland Clinic Taussig Cancer Institute. He joined the UT Southwestern Hematologic Malignancies, Transplant and Cellular Therapy program and focuses on clinical trial design and drug development for patients with myeloid malignancies, namely myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). Dr. Madanat is an active member of the MDS foundation, AAMDS foundation, the America Society of Hematology, and serves as a member on the national comprehensive cancer network (NCCN) guidelines for Myelodysplastic syndromes. Dr. Madanat has delivered several presentations and published numerous academic articles and book chapters that focus on the treatment of MDS and AML.